S. Langham

First name

S.

Last name

Langham

Stirnadel-Farrant, H. A., Golam, S. M., Naisbett-Groet, B., Gibson, D., Langham, J., Langham, S., & Samnaliev, M. (2023). Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK. Rheumatol Ther. http://doi.org/10.1007/s40744-023-00567-9

View

Stirnadel-Farrant, H. A., Golam, S. M., Naisbett-Groet, B., Gibson, D., Langham, J., Langham, S., & Samnaliev, M. (2023). Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK. Rheumatol Ther. http://doi.org/10.1007/s40744-023-00566-w

View

Langham, J., & Langham, S. (2017). European real world data sources to characterise flares in patients with systemic lupus erythematosus: A review. Value in Health.

View

Langham, S., Wright, A., Shaw, H., Bryson, S., & O\textquoterightLeary, S. (2017). Budget impact analysis of oral glycopyrronium bromide (Sialanar\texttrademark) for the symptomatic treatment of severe sialorrhoea (Drooling) in the UK setting. Value in Health.

View

Samnaliev, M., Barut, V., Weir, S., Langham, J., Langham, S., Wang, X., et al. (2021). Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract. http://doi.org/10.1093/rap/rkab071

View

Langham, J., Barut, V., Samnaliev, M., Langham, S., Weir, S., Wang, X., et al. (2021). Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract. http://doi.org/10.1093/rap/rkab061

View